A study launched in Lleida demonstrates the validity of the ultrasound pressure to predict the progression of atheromatous disease in patients with chronic kidney disease

Lleida, May 12 2016 The progression of chronic kidney disease (MRC) is associated with atheromatous disease progression (load of fat in the arteries), which confirms the association between the two diseases and explains why it is so high the incidence of cardiovascular disease (heart attacks or stroke, caused by the accumulation of fat in the arteries) in renal patients, according to an article published in the journal Clinical Journal of the American Society of Nephrology. The same article demonstrates the validity of the ultrasound pressure to predict the progression of atheromatous disease in patients with chronic kidney disease, a noninvasive technique, painless and economical that allows early diagnosis and prevent future vascular events. The article entitled "Predicting Progression of Subclinical Atheromatosis over 2 Years in Patients with Different Stages of CKD" is based on the results of the Nephron (National Observatory of Atherosclerosis in Nephrology), a project initiated and led by UDETMA Service Nephrology of the University Hospital Arnau de Vilanova and the Nephrology Research Group Experimental Biomedical Research Institute of Lleida. These early results have analyzed the tests conducted in 1553 patients with MRC, which became ultrasound of carotid and femoral arteries on two occasions separated by 24 months, to see his progress. Indeed, the use of techniques such as ultrasound blood also being carried out in the project's health bus', which will allow the health of the arteries and prevalence of kidney disease hidden in a sample of 9,000 people in the province of Lleida for three years. NEFRONA Project The project nephron is a multicenter observational study, involving more than 80 centers in Spain with the aim of establishing a model for assessing cardiovascular disease in patients with chronic kidney disease. The study also allowed to evaluate the usefulness of imaging techniques (eg ultrasound blood) and emerging biomarkers in predicting cardiovascular risk in 2,445 patients with kidney disease. This is a pioneering study that promotes research in vascular and collecting a database of images and biological samples representative of the population of Spain. The period of recruitment and follow-up of patients was from 2009 to 2014. During this period, a team of nurses and imaging traveled throughout the state noninvasive testing (ultrasound blood, determination of the ankle-brachial index) to nephrology services to hospitals and dialysis centers.